Catalyst Wire Dossier Catalyst Wire Dossier

Tumor antigen-loaded dendritic cell-derived exosome vaccine

· Gustave Roussy
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tumor antigen-loaded dendritic cell-derived exosome vaccine, covering 2018-03-29 to 2018-03-29. Get the full timeline:

Most recent: Clinical Trial Update: Trial of a Vaccination With Tumor Antigen-loaded Dendritic Cell-derived Exosomes [Phase 2]

See pricing